1. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature

   • Ritse M. Mann
   • Yvonne L. Hoogeveen
   • Carla Boetes

   Review Open access 15 February 2007 Pages: 1 - 14

   

2. TGFβ2 and TβRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells

   • Miriam B. Buck
   • Janet K. Coller
   • Cornelius Knabbe

   Preclinical Study 15 February 2007 Pages: 15 - 24

   

3. Analysis of telomere damage by fluorescence in situ hybridisation on micronuclei in lymphocytes of breast carcinoma patients after radiotherapy

   • Birendranath Banerjee
   • Sanjiv Sharma
   • M. Prakash Hande

   Preclinical Study 28 February 2007 Pages: 25 - 31

   

4. Effects of polyamine depletion by α-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells

   • John Yoonkeun Jun
   • James W. Griffith
   • Andrea Manni

   Preclinical Study 27 February 2007 Pages: 33 - 40

   

5. Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer

   • Petra van der Groep
   • Michael Hoelzel
   • Paul J. van Diest

   Preclinical Study Open access 27 February 2007 Pages: 41 - 47

   

6. Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation

   • Fabrice Journe
   • Guy Laurent
   • Jean-Jacques Body

   Preclinical Study 28 February 2007 Pages: 49 - 61

   

7. Activation of protein kinase A (PKA) signaling mitigates the antiproliferative and antiinvasive effects of α-difluoromethylornithine in breast cancer cells

   • Haifang Xu
   • Sharlene Washington
   • Andrea Manni

   Preclinical Study 27 February 2007 Pages: 63 - 70

   

8. Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen

   • Mahmoud R. Khoshnoud
   • Tommy Fornander
   • Lars-Erik Rutqvist

   Clinical Trial 15 February 2007 Pages: 71 - 78

   

9. Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us?

   • Karin Leunen
   • Maria Drijkoningen
   • Ignace Vergote

   Clinical Trial 13 April 2007 Pages: 79 - 86

10. Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)

    • Hiroyuki Takei
    • Kimito Suemasu
    • Toshio Tabei

    Clinical Trial 15 February 2007 Pages: 87 - 94

    

11. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1

    • Cheng-Ping Yu
    • Jyh-Cherng Yu
    • Amy Ming-Fang Yen

    Epidemiology 15 February 2007 Pages: 95 - 102

    

12. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

    • Agnès Fournier
    • Franco Berrino
    • Françoise Clavel-Chapelon

    Epidemiology 27 February 2007 Pages: 103 - 111

13. Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status

    • Jolanta Lissowska
    • Mia M. Gaudet
    • Montserrat Garcia-Closas

    Epidemiology 21 February 2007 Pages: 113 - 117

14. BARD1 and breast cancer in Poland

    • Anna Jakubowska
    • Cezary Cybulski
    • Jan Lubiński

    Epidemiology 27 February 2007 Pages: 119 - 122

15. Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study

    • Asha R. Kallianpur
    • Sang-Ah Lee
    • Wei Zheng

    Epidemiology 13 March 2007 Pages: 123 - 132

16. Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer

    • Rakhi P. Naik
    • David Jin
    • Linda T. Vahdat

    Preclinical Study/Clinical Trial/Epidemiology/Invited Commentary 15 February 2007 Pages: 133 - 138

    

17. Screening for ATM sequence alterations in African-American women diagnosed with breast cancer

    • Ariel E. Hirsch
    • David P. Atencio
    • Barry S. Rosenstein

    Preclinical Study/Clinical Trial/Epidmiology/Invited Commentary 27 February 2007 Pages: 139 - 144

18. Quantitative detection of circulating epithelial cells by Q-RT-PCR

    • Vladimir V. Iakovlev
    • Rashmi S. Goswami
    • Susan J. Done

    Preclinical Study/Clinical Trial/Epidemiology/Invited Commentary 09 March 2007 Pages: 145 - 154

    

19. No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriers

    • Muhammad U. Rashid
    • Diana Torres
    • Ute Hamann

    Letter to the Editor 15 February 2007 Pages: 155 - 156